Can you take Anbesol with Occlusal-HP?
1 drug interaction and 2 additional warnings found for the following 2 drugs:
- Anbesol (benzocaine topical)
- Occlusal-HP (salicylic acid topical)
Drug interactions
Moderate drug interactions
Moderate:
benzocaine topical salicylic acid topical
Applies to: Anbesol (benzocaine topical) and Occlusal-HP (salicylic acid topical)
Application of salicylic acid topical and benzocaine topical to the same area of skin may increase the amount of benzocaine topical absorbed into the skin and intensify its local effects or side effects. Your healthcare provider may be able to prescribe alternatives that do not interact. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Food/lifestyle interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Disease interactions
2 potential interactions Applies to: 2 conditions, including Methemoglobinemia and G-6-PD Deficiency.
G-6-PD Deficiency
Moderate:
Anbesol
The benzocaine topical in Anbesol has a moderate potential interaction with G-6-PD Deficiency.
Rarely, benzocaine has induced methemoglobinemia resulting in respiratory distress and cyanosis. Therapy with benzocaine should be administered cautiously to patients with or predisposed to methemoglobinemia. If life-threatening or severe methemoglobinemia develops, methylene blue infused at a dosage of 1 to 2 mg/kg body weight will rapidly reverse or improve the condition except in G-6-PD-deficient patients.
Methemoglobinemia
Moderate:
Anbesol
The benzocaine topical in Anbesol has a moderate potential interaction with Methemoglobinemia.
Rarely, benzocaine has induced methemoglobinemia resulting in respiratory distress and cyanosis. Therapy with benzocaine should be administered cautiously to patients with or predisposed to methemoglobinemia. If life-threatening or severe methemoglobinemia develops, methylene blue infused at a dosage of 1 to 2 mg/kg body weight will rapidly reverse or improve the condition except in G-6-PD-deficient patients.
Report options
More resources
Anbesol
A total of 56 drugs are known to interact with Anbesol.
- Anbesol is in the drug class topical anesthetics.
- Anbesol is used to treat the following conditions:
Occlusal-HP
A total of 204 drugs are known to interact with Occlusal-HP.
- Occlusal-hp is in the following drug classes: topical acne agents, topical keratolytics.
- Occlusal-hp is used to treat the following conditions:
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.